CLNN (clene.com) Bozor qiymatining balans qiymatiga nisbati
Clene Inc. (CLNN) nevrologik dori vositalari uchun maqsadli ta'minot zanjirlarini yo'lga qo'ymoqda va kontragentlarni diversifikatsiya qilish orqali uzilishlar xavfini kamaytirmoqda, bu esa daromadlarni -1.98 darajasida mustahkamlaydi. Ushbu narxlar grafigi aktivning bozor dinamikasini tasdiqlaydi. Kompaniya ALS bemorlarida neyron energiyasini saqlash uchun oltin-kristall nanoterapiyasini ishlab chiqmoqda. Markaziy nerv tizimi (CNS) dori vositalarining sintezi mukammal tekshirilgan steril laboratoriyalarda amalga oshiriladi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_CLNN_-_Clene-Inc._-_Capitalization-to-Book-Value-Ratio "CLNN Clene Nanomedicine Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 27.10.2026) | 👁️GURU.Markets👁️")
Clene Inc. (CLNN) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Clene Inc, CLNN
Clene Inc. bemorlarning yuqori sodiqligi va ilmiy nufuzidan foydalangan holda, ALS terapiyasi uchun innovatsion neyrohimoyani ishlab chiqmoqda. Ushbu ko'rsatkich barcha aksiyalarning bozor qiymatini sof aktivlarning balans qiymati bilan solishtiradi. P/B koeffitsiyenti orqali kompaniyaning baholash tarixini tahlil qilish yordamida biznesning moddiy resurslariga nisbatan haddan tashqari qimmat baholanganlik darajasini aniqlash mumkin. Ushbu narx harakati tartibga soluvchi qarorlar bo'yicha bozor kutuvlarini aks ettiradi. Investorlar tarixiy medianalarga qaytish a’loida kirish nuqtalarini aniqlash uchun ushbu farqdan foydalanadilar.
Toʻgʻridan-toʻgʻri raqobatchilar
Bozor qiymatining balans qiymatiga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati AMLX|Kapitallashuvning sof aktivlarga nisbati TRVI|Bozor qiymatining balans qiymatiga nisbati Praxis Precision Medicines, Inc. (PRAX)|Bozor qiymatining balans qiymatiga nisbati Anavex (AVXL)|CBLL: Bozor kapitallashuvining balans qiymatiga nisbati|Prothena - Bozor qiymatining balans qiymatiga koeffitsiyenti|Alector Therapeutics (ALEC) - Bozor qiymatining balans qiymatiga nisbati|ANNX - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati OMER|Bozor qiymatining balans qiymatiga koeffitsiyenti Neurogene Inc|ACIU - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Voyager Corp|NMRA (Neumora Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SCLX (scilexholding.com)|TVGN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Alpha Cognition Inc ACOG|CGTX: Bozor kapitallashuvining balans qiymatiga nisbati|Inhibikase Pharma (IKT) - Kapitallashuvning sof aktivlarga nisbati|Cassava Sciences, Inc. - Kapitallashuvning sof aktivlarga nisbati|Assertio (ASRT) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati COYA|Kapitallashuvning sof aktivlarga nisbati VTGN|Bozor qiymatining balans qiymatiga nisbati Ovid Therapeutics Inc. (OVID)|Bozor qiymatining balans qiymatiga nisbati ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Bozor qiymatining balans qiymatiga nisbati|Alterity Therapeutics Ltd. - Kapitallashuvning balans qiymatiga nisbati|PepGen Corp (PEPG) - Bozor qiymatining balans qiymatiga nisbati|JUNS: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Relmada|Annovis Bio Corporation (ANVS) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GRCE (Grace Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti fireflyneuro.com (AIFF)|Kapitallashuvning sof aktivlarga nisbati KLTO|Bozor kapitallashuvining balans qiymatiga nisbati NRSN (neurosense-tx.com)|Bozor qiymatining balans qiymatiga nisbati Reviva Pharmaceuticals Holdings|MetaVia Inc. - Balans qiymatiga nisbatan bozor qiymati|NRXS (NeurAxis, Inc.) - Bozor qiymatining balans qiymatiga nisbati|HSDT - Bozor qiymatining balans qiymatiga koeffitsiyenti|PASG (passagebio.com) - Bozor kapitallashuvining balans qiymatiga nisbati|NEUP (Neuphoria Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Minerva Neurosciences Corp|Bozor qiymatining balans qiymatiga nisbati Athira Pharma Corp|Addex Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ALZN (alzamend.com)|CYCN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Bozor kapitallashuvining balans qiymatiga nisbati|Cortigent, Inc. (CRGT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Avenue Therapeutics ATXI|brainstorm-cell.com (BCLI) - Balans qiymatiga nisbatan bozor qiymati|CARA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CHRO|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics ELYM|Kapitallashuvning balans qiymatiga nisbati intracellulartherapies.com (ITCI)|Longboard Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|MRNS - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati NKGN (NKGen Biotech)|NRBO - Balans qiymatiga nisbatan bozor kapitallashuvi|SAGE (Sage Therapeutics, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|SNPX (Synaptogenix, Inc) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc.|Bozor qiymatining balans qiymatiga nisbati VIGL|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. WENA|Kapitallashuvning balans qiymatiga nisbati CERE (Cerevel Therapeutics Inc)